# Episode 505 : ASCO 2026 - RAMPART

Page: https://stenobird.com/podcast/the-uromigos-1214845/episode-505-asco-2026-rampart
Text version: https://stenobird.com/podcast/the-uromigos-1214845/episode-505-asco-2026-rampart.md
Podcast: [The Uromigos](https://stenobird.com/podcast/the-uromigos-1214845)
Published: 2026-05-30T15:00:00+00:00
Episode link: https://podcasters.spotify.com/pod/show/the-uromigos/episodes/Episode-505--ASCO-2026---RAMPART-e3jl61f
Audio file: https://anchor.fm/s/13347ea8/podcast/play/120280559/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-4-20%2F424542149-44100-2-d2b1721d3afce.m4a
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/the-uromigos-1214845/episodes/episode-505-asco-2026-rampart
Duration seconds: 1771

## Resource

James Larkin joins us to discuss the durvalumab monotherapy arm from RAMPART and we discuss the role of CTLA-4 inhibition broadly and how these data contribute to the adjuvant RCC landscape.

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/the-uromigos-1214845/episodes/episode-505-asco-2026-rampart/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/the-uromigos-1214845/episode-505-asco-2026-rampart.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.